Clinical Characteristics and Prognosis of Gastric Cancer Patients with BRCA 1/2 Germline Mutations: Report of Ten Cases and a Literature Review.
Halpern NaamaAlbert GrinshpunBen BoursiTalia GolanOfer MargalitDan AderkaEitan FriedmanYael LaitmanAyala HubertLuna KadouriTamar HamburgerInbal Barnes-KedarZohar LeviIrit Ben-AharonBaruch BrennerYael GoldbergTamar PeretzEinat Shacham-ShmueliPublished in: OncoTargets and therapy (2020)
These preliminary data suggest that gBRCAm in GC patients are associated with a favorable prognosis. Furthermore, gBRCAm might be a predictive biomarker to DNA-damaging agents response in GC patients, similarly to its established role in other malignancies. Further research is needed to confirm our findings.